Harnessing natures arsenal: targeting the tgf-/smad cascade with novel natural anti-fibrotic agents
For now, both drugs are positioned as potentially transformative next-generation treatments that could offer advantages over existing single-target GLP-1 agonists
SGLT2 inhibitors SGLT2 and SGLT1 are responsible for actively transporting glucose across the proximal convoluted tubule (PCT) cells in the kidney, each with different capacities
Wendisch, [email protected] This article was submitted to Industrial Biotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
enterica Serovar enteritidis, which is identical to the strain used in the oral infection study
Stimulants irritate the intestinal lining to trigger muscle contractions, usually working in 6 to 12 hours